Home > Healthcare > Pharmaceuticals > Finished Drug Form > Branded Generics Market

Branded Generics Market Share

Report ID: GMI6565
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Branded Generics Market Share

Major market players operating in the branded generics market include:

Teva Pharmaceutical Industries Ltd
Lupin
Sanofi
Sun Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd
Endo International plc

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The branded generics industry was worth USD 238.4 billion in 2022 and is estimated to grow at 6.1% CAGR from 2023-2032, driven by the rising number of patent expiry boosting the demand for branded generics.

The anti-hypertensive segment held a 16.7% share of the market in 2022 and is set to witness significant growth through 2032 attributed to the increasing prevalence of hypertension.

The North America branded generics market accounted for a 40.8% market share in 2022 and is poised to expand rapidly through 2032 due to the presence of a robust healthcare infrastructure and the rising emphasis on cost-effective treatments.

Demand for calcium aluminosilicate recorded USD 0.7 billion in 2022 and may expand at a significant pace from 2023-2032 due to rising concerns over water scarcity along with the need to ensure safe and clean drinking water